[go: up one dir, main page]

AR117298A1 - PEPTIDE BINDER - Google Patents

PEPTIDE BINDER

Info

Publication number
AR117298A1
AR117298A1 ARP190103608A ARP190103608A AR117298A1 AR 117298 A1 AR117298 A1 AR 117298A1 AR P190103608 A ARP190103608 A AR P190103608A AR P190103608 A ARP190103608 A AR P190103608A AR 117298 A1 AR117298 A1 AR 117298A1
Authority
AR
Argentina
Prior art keywords
sulfonamide
conjugate
formula
peptide binder
active ingredient
Prior art date
Application number
ARP190103608A
Other languages
Spanish (es)
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of AR117298A1 publication Critical patent/AR117298A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente se refiere a una sulfonamida de la fórmula (2); un conjugado que comprende una sulfonamida de la fórmula (1) y un ingrediente farmacéuticamente activo; un proceso de preparación de un conjugado que comprende una sulfonamida de la fórmula (1) y un ingrediente farmacéuticamente activo; una composición farmacéutica que comprende el conjugado que comprende una sulfonamida de la fórmula (1) y un ingrediente farmacéuticamente activo; y al uso del conjugado como un medicamento.This refers to a sulfonamide of the formula (2); a conjugate comprising a sulfonamide of the formula (1) and a pharmaceutically active ingredient; a process for preparing a conjugate comprising a sulfonamide of the formula (1) and a pharmaceutically active ingredient; a pharmaceutical composition comprising the conjugate comprising a sulfonamide of the formula (1) and a pharmaceutically active ingredient; and to the use of the conjugate as a medicine.

ARP190103608A 2018-12-11 2019-12-11 PEPTIDE BINDER AR117298A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18306657 2018-12-11

Publications (1)

Publication Number Publication Date
AR117298A1 true AR117298A1 (en) 2021-07-28

Family

ID=65279373

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP190103609A AR117299A1 (en) 2018-12-11 2019-12-11 INSULIN CONJUGATES
ARP190103608A AR117298A1 (en) 2018-12-11 2019-12-11 PEPTIDE BINDER
ARP190103610A AR117300A1 (en) 2018-12-11 2019-12-11 INSULIN ANALOGUES WITH REDUCED INSULIN RECEPTOR BINDING AFFINITY

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP190103609A AR117299A1 (en) 2018-12-11 2019-12-11 INSULIN CONJUGATES

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP190103610A AR117300A1 (en) 2018-12-11 2019-12-11 INSULIN ANALOGUES WITH REDUCED INSULIN RECEPTOR BINDING AFFINITY

Country Status (1)

Country Link
AR (3) AR117299A1 (en)

Also Published As

Publication number Publication date
AR117300A1 (en) 2021-07-28
AR117299A1 (en) 2021-07-28

Similar Documents

Publication Publication Date Title
DOP2022000124A (en) PYRAZOLIL DERIVATIVES USEFUL AS ANTICANCER AGENTS
UY36465A (en) CARBAMOILPIRIDONE POLICYCLY COMPOUNDS AND THEIR PHARMACEUTICAL USE
MX2021006969A (en) Peptide binder.
MX386981B (en) PYRROLOPYRIMIDINE COMPOUNDS USED AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS.
MX2015009772A (en) Spiro-lactam nmda receptor modulators and uses thereof.
CR20170563A (en) BENZOXACEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE.
CU20150096A7 (en) AMIDA COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR HIV TREATMENT
EA201491479A1 (en) DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS
MX2018011831A (en) SOLUBLE C5aR ANTAGONISTS.
PE20151437A1 (en) SPIRO-LACTAMA NMDA RECEIVER MODULATORS AND THEIR USES
GT200600445A (en) SOLID PHARMACEUTICAL PRESENTATION FORMS OF ORAL ADMINISTRATION WITH QUICK RELEASE OF THE ACTIVE PRINCIPLE.
DOP2011000343A (en) PIRIDINE TIENO DERIVATIVES [2,3-B] AS VIRAL REPLICATION INHIBITORS
UY37741A (en) INDOLINA DERIVATIVES REPLACED AS INHIBITORS OF THE DENGUE VIRUS REPLICATION
AR104984A1 (en) SELECTIVE COMPOUNDS FOR PYY AND ITS USES
NZ763123A (en) Pde9 inhibitor and use thereof
NZ735575A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
CO2019000945A2 (en) Modulators of the nmda spiro-lactam receptor and use thereof
CO2023013050A2 (en) Psilocybin compositions, methods of preparing them and methods of using them
MX393586B (en) Substituted indoline derivatives as dengue viral replication inhibitors
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
CO2019000943A2 (en) Modulators of the nmda spiro-lactam receptor and use thereof
DOP2019000100A (en) DERIVATIVES OF NAFTIRIDINONE AND ITS USE IN THE TREATMENT OF ARRITMIA
UY38228A (en) TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER
CO2021008962A2 (en) Active Testosterone Ester Derivatives, Compositions and Uses Thereof
AR114418A1 (en) CYCLIC COMPOUND OF METHYLACTAM AND ITS PHARMACEUTICAL USE